Evidence map›Paper›PMID 33576079›Full record

ArticleBrain pathology (Zurich, Switzerland)2021

Automated and unbiased discrimination of ALS from control tissue at single cell resolution.

Cathleen Hagemann, Giulia E Tyzack, Doaa M Taha, Helen Devine, Linda Greensmith, Jia Newcombe, Rickie Patani, Andrea Serio, Raphaëlle Luisier

Abstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cathleen HagemannThe Francis Crick Institute, London, UK.ORCID 0000-0002-9900-3556
Giulia E TyzackThe Francis Crick Institute, London, UK.ORCID 0000-0001-5730-2112
Doaa M TahaThe Francis Crick Institute, London, UK.
Helen DevineDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0002-0744-6270
Linda GreensmithDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0002-7839-5052
Jia NewcombeNeuroResource, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0001-9609-7975
Rickie PataniThe Francis Crick Institute, London, UK.ORCID 0000-0002-3825-7675
Andrea SerioThe Francis Crick Institute, London, UK.ORCID 0000-0002-7271-1878
Raphaëlle LuisierIdiap Research Institute, Martigny, Switzerland.ORCID 0000-0002-5657-2943

Funding

Cancer Research UK FC010110Medical Research Council FC010110Medical Research Council MR/N020820/1Medical Research Council MR/S006591/1Wellcome TrustWellcome Trust 213949/Z/18/ZWellcome Trust FC010110
6 · The paper itself

Abstract

Histopathological analysis of tissue sections is invaluable in neurodegeneration research. However, cell-to-cell variation in both the presence and severity of a given phenotype is a key limitation of this approach, reducing the signal to noise ratio and leaving unresolved the potential of single-cell scoring for a given disease attribute. Here, we tested different machine learning methods to analyse high-content microscopy measurements of hundreds of motor neurons (MNs) from amyotrophic lateral sclerosis (ALS) post-mortem tissue sections. Furthermore, we automated the identification of phenotypically distinct MN subpopulations in VCP- and SOD1-mutant transgenic mice, revealing common morphological cellular phenotypes. Additionally we established scoring metrics to rank cells and tissue samples for both disease probability and severity. By adapting this paradigm to human post-mortem tissue, we validated our core finding that morphological descriptors robustly discriminate ALS from control healthy tissue at single cell resolution. Determining disease presence, severity and unbiased phenotypes at single cell resolution might prove transformational in our understanding of ALS and neurodegeneration more broadly.

Indexed as

Amyotrophic Lateral SclerosisMotor NeuronsSpinal CordAnimalsHumansMiceMice, TransgenicMitochondriaPhenotypeSuperoxide DismutaseSuperoxide DismutaseALShistopathologymachine learningprotein mislocalization

Identifiers

PMID33576079
PMCPMC8412073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.